While AI has been widely enlisted in the fight against the coronavirus, those on the front lines of patient care aren’t the only ones who’ve turned to the suite of new technologies for assistance in moving healthcare forward. As a recent article in Genetic Engineering & Biotechnology News noted, many stakeholders in biotech are beginning to explore the potential for AI to help them develop new drugs or repurpose existing drugs to treat COVID-19.
Source: www.healthcareitnews.com